These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23353149)
1. [Interferon-γ enhances human γδ T cell-mediated osteosarcoma cell killing in vitro]. Li Z; Tang J; Ye Z Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):22-5. PubMed ID: 23353149 [TBL] [Abstract][Full Text] [Related]
2. IFN-γ enhances HOS and U2OS cell lines susceptibility to γδ T cell-mediated killing through the Fas/Fas ligand pathway. Li Z; Xu Q; Peng H; Cheng R; Sun Z; Ye Z Int Immunopharmacol; 2011 Apr; 11(4):496-503. PubMed ID: 21238618 [TBL] [Abstract][Full Text] [Related]
3. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma]. Li Z; Tang J; Sun L; Ye Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):6-9. PubMed ID: 23294710 [TBL] [Abstract][Full Text] [Related]
4. Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells Wang Z; Wang Z; Li S; Li B; Sun L; Li H; Lin P; Wang S; Teng W; Zhou X; Ye Z Front Immunol; 2018; 9():1239. PubMed ID: 29910819 [TBL] [Abstract][Full Text] [Related]
5. [Amplification of γδ T cells in PBMCs of healthy donors and osteosarcoma patients stimulated by zoledronate]. Li ZX; Sun LL; Cheng RL; Sun ZW; Ye ZM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):822-4. PubMed ID: 22863589 [TBL] [Abstract][Full Text] [Related]
6. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate. Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685 [TBL] [Abstract][Full Text] [Related]
7. Celastrol increases osteosarcoma cell lysis by γδ T cells through up-regulation of death receptors. Li Z; Zhang J; Tang J; Wang R Oncotarget; 2016 Dec; 7(51):84388-84397. PubMed ID: 27768597 [TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells. Muraro M; Mereuta OM; Carraro F; Madon E; Fagioli F Cell Immunol; 2007 Oct; 249(2):63-72. PubMed ID: 18163982 [TBL] [Abstract][Full Text] [Related]
9. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells. Knight A; Mackinnon S; Lowdell MW Cytotherapy; 2012 Oct; 14(9):1110-8. PubMed ID: 22800570 [TBL] [Abstract][Full Text] [Related]
10. Rapid and transient activation of γδ T cells to IFN-γ production, NK cell-like killing, and antigen processing during acute virus infection. Toka FN; Kenney MA; Golde WT J Immunol; 2011 Apr; 186(8):4853-61. PubMed ID: 21383249 [TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma sensitizes osteosarcoma cells to Fas-induced apoptosis by up-regulating Fas receptors and caspase-8. Inaba H; Glibetic M; Buck S; Ravindranath Y; Kaplan J Pediatr Blood Cancer; 2004 Dec; 43(7):729-36. PubMed ID: 15390286 [TBL] [Abstract][Full Text] [Related]
12. Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells. Liu M; Sun LL; Li YJ; Li HY; Zhang J; Li BH; Ye ZM Int Immunopharmacol; 2015 Sep; 28(1):160-7. PubMed ID: 26071219 [TBL] [Abstract][Full Text] [Related]
13. Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens. Iwasaki M; Tanaka Y; Kobayashi H; Murata-Hirai K; Miyabe H; Sugie T; Toi M; Minato N Eur J Immunol; 2011 Feb; 41(2):345-55. PubMed ID: 21268005 [TBL] [Abstract][Full Text] [Related]
14. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy. Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372 [TBL] [Abstract][Full Text] [Related]
15. Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells. Oberg HH; Peipp M; Kellner C; Sebens S; Krause S; Petrick D; Adam-Klages S; Röcken C; Becker T; Vogel I; Weisner D; Freitag-Wolf S; Gramatzki M; Kabelitz D; Wesch D Cancer Res; 2014 Mar; 74(5):1349-60. PubMed ID: 24448235 [TBL] [Abstract][Full Text] [Related]
16. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients. Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731 [TBL] [Abstract][Full Text] [Related]
17. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells. Lafleur EA; Jia SF; Worth LL; Zhou Z; Owen-Schaub LB; Kleinerman ES Cancer Res; 2001 May; 61(10):4066-71. PubMed ID: 11358827 [TBL] [Abstract][Full Text] [Related]
18. The effect of phloretin on human γδ T cells killing colon cancer SW-1116 cells. Zhu SP; Liu G; Wu XT; Chen FX; Liu JQ; Zhou ZH; Zhang JF; Fei SJ Int Immunopharmacol; 2013 Jan; 15(1):6-14. PubMed ID: 23174508 [TBL] [Abstract][Full Text] [Related]
19. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells. Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate. Sugai S; Yoshikawa T; Iwama T; Tsuchiya N; Ueda N; Fujinami N; Shimomura M; Zhang R; Kaneko S; Uemura Y; Nakatsura T Int J Oncol; 2016 May; 48(5):1794-804. PubMed ID: 26936487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]